{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:26:35Z","timestamp":1789568795826,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Medical Award Foundation","award":["YXJL-2020-1223-0320"],"award-info":[{"award-number":["YXJL-2020-1223-0320"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03932-w","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:49:55Z","timestamp":1745956195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum cholinesterase combined with platelet-to-hemoglobin ratio for predicting survival prognosis in stage I-III colorectal cancer patients undergoing radical surgery: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Luyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongnan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhuang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhe","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"3","key":"3932_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA-CANCER J CLIN"},{"key":"3932_CR2","unstructured":"National Cancer Institute. SEER Cancer Stat Facts. Colorectal Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html(accessed Sept 19, 2024)."},{"issue":"3","key":"3932_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA-CANCER J CLIN. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA-CANCER J CLIN"},{"issue":"4","key":"3932_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.burns.2020.10.027","volume":"47","author":"K Schmidt","year":"2020","unstructured":"Schmidt K, Zivkovic AR, Thiele M, Horter J, Brenner T, Weigand MA, Kleinschmidt S, Hofer S. Point-of-care measured serum cholinesterase activity predicts patient outcome following severe burns. BURNS. 2020;47(4):863\u201372. https:\/\/doi.org\/10.1016\/j.burns.2020.10.027.","journal-title":"BURNS"},{"issue":"1","key":"3932_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","volume":"4","author":"L Santarpia","year":"2012","unstructured":"Santarpia L, Grandone I, Contaldo F, Pasanisi F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J CACHEXIA SARCOPENI. 2012;4(1):31\u20139. https:\/\/doi.org\/10.1007\/s13539-012-0083-5.","journal-title":"J CACHEXIA SARCOPENI"},{"issue":"1","key":"3932_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12885-022-09212-0","volume":"22","author":"H Ran","year":"2022","unstructured":"Ran H, Ma J, Cai L, Zhou H, Yuan Z, Chen Y, Chang W, Huang Y, Xiao Y. Serum cholinesterase May independently predict prognosis in non-small-cell lung cancer. BMC Cancer. 2022;22(1):93. https:\/\/doi.org\/10.1186\/s12885-022-09212-0.","journal-title":"BMC Cancer"},{"issue":"5","key":"3932_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s00066-019-01430-z","volume":"195","author":"N Poetsch","year":"2019","unstructured":"Poetsch N, Sturdza A, Aust S, Polterauer S, Grimm C, Schwameis R, P\u00f6tter R, Koelbl H, Reinthaller A, Seebacher V. The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy. STRAHLENTHER ONKOL. 2019;195(5):430\u201340. https:\/\/doi.org\/10.1007\/s00066-019-01430-z.","journal-title":"STRAHLENTHER ONKOL"},{"issue":"2","key":"3932_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.21873\/anticanres.17462","volume":"45","author":"T Takishima","year":"2025","unstructured":"Takishima T, Kobayashi Y, Matsukida S, Kai W, Takano Y, Kanno H, Morikawa T, Hannyu N, Eto K. Negative impact of low serum cholinesterase on Short- and Long-term outcomes in elderly patients undergoing scheduled surgery for colorectal Cancer. ANTICANCER RES. 2025;45(2):743\u201350. https:\/\/doi.org\/10.21873\/anticanres.17462.","journal-title":"ANTICANCER RES"},{"issue":"4","key":"3932_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ags3.12794","volume":"8","author":"K Nakamura","year":"2024","unstructured":"Nakamura K, Seishima R, Matsui S, Shigeta K, Okabayashi K, Kitagawa Y. Preoperative serum cholinesterase as a prognostic factor in patients with colorectal cancer. Ann Gastroenterol Surg. 2024;8(4):650\u20139. https:\/\/doi.org\/10.1002\/ags3.12794.","journal-title":"Ann Gastroenterol Surg"},{"issue":"4suppl","key":"3932_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1200\/jco.2017.35.4_suppl.463","volume":"35","author":"X Li","year":"2017","unstructured":"Li X, Xing Y, Lin Z, Hong Y, Wu D, Wang T, Ma X, Huang M, Dong M, Lin Q, Wu X. Platelet-to-hemoglobin ratio to predict progression-free survival for patients with locally advanced hepatocellular carcinoma. J CLIN ONCOL. 2017;35(4suppl):463\u2013463. https:\/\/doi.org\/10.1200\/jco.2017.35.4_suppl.463.","journal-title":"J CLIN ONCOL"},{"key":"3932_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00639-6","author":"S Li","year":"2024","unstructured":"Li S, Lu Z, Wu S, Chu T, Li B, Qi F, Zhao Y, Nie G. The dynamic role of platelets in cancer progression and their therapeutic implications. NAT REV CANCER. 2024. https:\/\/doi.org\/10.1038\/s41568-023-00639-6. 24 NAT REV CANCER.","journal-title":"NAT REV CANCER"},{"key":"3932_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.11.045","author":"CE McAleese","year":"2021","unstructured":"McAleese CE, Choudhury C, Butcher NJ, Minchin RF. Hypoxia-mediated drug resistance in breast cancers. CANCER LETT. 2021. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.045. 502 CANCER LETT.","journal-title":"CANCER LETT"},{"key":"3932_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2019.11.036","volume":"501","author":"Z Hu","year":"2019","unstructured":"Hu Z, Tan S, Chen S, Qin S, Chen H, Qin S, Huang Z, Zhou F, Qin X. Diagnostic value of hematological parameters platelet to lymphocyte ratio and hemoglobin to platelet ratio in patients with colon cancer. CLIN CHIM ACTA. 2019;501:48\u201352. https:\/\/doi.org\/10.1016\/j.cca.2019.11.036.","journal-title":"CLIN CHIM ACTA"},{"issue":"4","key":"3932_CR14","doi-asserted-by":"publisher","first-page":"e23153","DOI":"10.1002\/jcla.23153","volume":"34","author":"CJ Mo","year":"2020","unstructured":"Mo CJ, Hu ZJ, Qin SZ, Chen HP, Huang L, Li S, Cao Z. Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer. J CLIN LAB ANAL. 2020;34(4):e23153. https:\/\/doi.org\/10.1002\/jcla.23153.","journal-title":"J CLIN LAB ANAL"},{"issue":"8","key":"3932_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","volume":"40","author":"NN Baxter","year":"2021","unstructured":"Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, Mahmoud N, Morris AM, Ruiz-Garcia E, You YN, Meyerhardt JA. Adjuvant therapy for stage II Colon cancer: ASCO guideline update. J CLIN ONCOL. 2021;40(8):892\u2013910. https:\/\/doi.org\/10.1200\/JCO.21.02538.","journal-title":"J CLIN ONCOL"},{"key":"3932_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-022-04119-5","author":"Y Takano","year":"2022","unstructured":"Takano Y, Haruki K, Tsukihara S, Ito D, Kanno H, Son K, Hanyu N, Eto K. The impact of low serum cholinesterase levels on survival in patients with colorectal cancer. INT J COLORECTAL DIS. 2022. https:\/\/doi.org\/10.1007\/s00384-022-04119-5. 37 INT J COLORECTAL DIS.","journal-title":"INT J COLORECTAL DIS"},{"issue":"1","key":"3932_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12903-023-02937-9","volume":"23","author":"B Yilmaz","year":"2023","unstructured":"Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy. BMC Oral Health. 2023;23(1):231. https:\/\/doi.org\/10.1186\/s12903-023-02937-9.","journal-title":"BMC Oral Health"},{"key":"3932_CR18","doi-asserted-by":"publisher","unstructured":"Irawan C, Rachman A, Rahman P, Mansjoer A. Role of pretreatment Hemoglobin-to-Platelet ratio in predicting survival outcome of locally advanced nasopharyngeal carcinoma patients. J CANCER EPIDEMIOL. 2021;2021(J CANCER EPIDEMIOL). https:\/\/doi.org\/10.1155\/2021\/1103631.","DOI":"10.1155\/2021\/1103631"},{"issue":"4suppl","key":"3932_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1200\/jco.2016.34.4_suppl.667","volume":"34","author":"K Gonda","year":"2016","unstructured":"Gonda K, Shibata M, Nakamura I, Ohki S, Kono K, Shimura T, Takenoshita S. Multiple immunological mechanisms of cancer cachexia in patients with solid tumors. J CLIN ONCOL. 2016;34(4suppl):667\u2013667. https:\/\/doi.org\/10.1200\/jco.2016.34.4_suppl.667.","journal-title":"J CLIN ONCOL"},{"key":"3932_CR20","doi-asserted-by":"publisher","unstructured":"Kasprzak A. The role of tumor microenvironment cells in colorectal Cancer (CRC) Cachexia. Int J Mol Sci. 2021;22(4). https:\/\/doi.org\/10.3390\/ijms22041565.","DOI":"10.3390\/ijms22041565"},{"issue":"11","key":"3932_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/MEG.0b013e32834aa4bb","volume":"23","author":"EJ Huisman","year":"2011","unstructured":"Huisman EJ, Trip EJ, Siersema PD, van Hoek B, van Erpecum KJ. Protein energy malnutrition predicts complications in liver cirrhosis. EUR J GASTROEN HEPAT. 2011;23(11):982\u20139. https:\/\/doi.org\/10.1097\/MEG.0b013e32834aa4bb.","journal-title":"EUR J GASTROEN HEPAT"},{"issue":"1","key":"3932_CR22","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.eclnm.2009.10.006","volume":"5","author":"I Grandone","year":"2010","unstructured":"Grandone I, Santarpia L, Alfonsi L, Pagano M, Pasanisi F, Contaldo F. Serum cholinesterase as indicator of parenteral nutrition efficacy in protein energy malnutrition: four case reports. E Spen Eur E J Clin Nutr Metab. 2010;5(1):e6\u20139. https:\/\/doi.org\/10.1016\/j.eclnm.2009.10.006.","journal-title":"E Spen Eur E J Clin Nutr Metab"},{"issue":"11","key":"3932_CR23","doi-asserted-by":"publisher","first-page":"11714","DOI":"10.21037\/apm-21-2889","volume":"10","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yang X, Yang J. Cholinesterase level is a predictor of systemic inflammatory response syndrome and complications after cardiopulmonary bypass. ANN PALLIAT MED. 2021;10(11):11714\u201320. https:\/\/doi.org\/10.21037\/apm-21-2889.","journal-title":"ANN PALLIAT MED"},{"key":"3932_CR24","doi-asserted-by":"publisher","unstructured":"Beringer A, Thiam ND, Molle J, Bartosch B, Miossec P. P077 effects of il-17 and the hepatocyte\u2013mononuclear cell interactions in the hepatic inflammatory response. ANN RHEUM DIS. 2018;77. https:\/\/doi.org\/10.1136\/annrheumdis-2018-EWRR2018.94. A45 - A46.","DOI":"10.1136\/annrheumdis-2018-EWRR2018.94"},{"key":"3932_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pharmthera.2015.11.005","volume":"157","author":"B Tesfamariam","year":"2015","unstructured":"Tesfamariam B. Involvement of platelets in tumor cell metastasis. PHARMACOL THERAPEUT. 2015;157:112\u20139. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.11.005.","journal-title":"PHARMACOL THERAPEUT"},{"issue":"19Supple","key":"3932_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1158\/1538-7445.am2014-28","volume":"74","author":"R M\u00f6nch","year":"2014","unstructured":"M\u00f6nch R, Grimmig T, Kannen V, Germer C, Waaga-Gasser A, Gasser M. Abstract 28: the influence of PDGF and VEGF on tumor proliferation in colon cancer. CANCER RES. 2014;74(19Supple):28\u201328. https:\/\/doi.org\/10.1158\/1538-7445.am2014-28.","journal-title":"CANCER RES"},{"issue":"16suppl","key":"3932_CR27","doi-asserted-by":"publisher","first-page":"e14552","DOI":"10.1200\/jco.2024.42.16_suppl.e14552","volume":"42","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li T, Ding L, Wang J, Chen C, Liu T, Liu Y, Li Q, Wang C, Huo R, Wang H, Tian T, Zhang C, Pan B, Zhou J, Fan J, Yang X, Yang W, Wang B, Guo W. Platelet-mediated Circulating tumor cell evasion from natural killer cell killing via immune checkpoint CD155-TIGIT. J CLIN ONCOL. 2024;42(16suppl):e14552\u201314552. https:\/\/doi.org\/10.1200\/jco.2024.42.16_suppl.e14552.","journal-title":"J CLIN ONCOL"},{"issue":"23","key":"3932_CR28","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.26355\/eurrev_201712_13921","volume":"21","author":"YY Li","year":"2017","unstructured":"Li YY, Zheng YL. Hypoxia promotes invasion of retinoblastoma cells in vitro by upregulating HIF-1\u03b1\/MMP9 signaling pathway. EUR REV MED PHARMACO. 2017;21(23):5361\u20139. https:\/\/doi.org\/10.26355\/eurrev_201712_13921.","journal-title":"EUR REV MED PHARMACO"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03932-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03932-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:50:02Z","timestamp":1745956202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03932-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3932"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03932-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Harbin Medical University Cancer Hospital (KY2021-30). As this was a retrospective observational study, the Ethics Review Committee confirmed that individual informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"319"}}